Skip to content
Dx

ICD-10-CM 2027 diagnosis code

R87.61Abnormal cytological findings in specimens from cervix uteri

Not billable — use a more specific code

R87.61 is a header code, so it can't be reported by itself. Choose one of the 9 more specific codes beneath it.

Code unchanged since ICD-10-CM took effect on October 1, 2015. Source: official FY2027 ICD-10-CM release from CDC/NCHS and CMS. Page updated September 29, 2026. About our data

About R87.61

R87.61 is the ICD-10-CM diagnosis code for abnormal cytological findings in specimens from cervix uteri. It belongs to category R87 (abnormal findings in specimens from female genital organs), block R83-R89 (abnormal findings on examination of other body fluids, substances and tissues, without diagnosis) and chapter 18 (symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified). It is a header code, so it can't be reported by itself; one of its 9 subcodes must be used instead.

Within R87.6 (abnormal cytological findings in specimens from female genital organs), R87.61 is specifically for abnormal cytological findings in specimens from cervix uteri. Related codes cover vagina (R87.62) and other female genital organs (R87.69).

To report this condition, pick the subcode that matches the documentation: R87.610 ((ASC-US)), R87.611 ((ASC-H)), R87.612 ((LGSIL)), R87.613 ((HGSIL)), R87.614 (cervix), R87.615 (cervix), R87.616 (zone), R87.618 (uteri) and 1 more.

Don't report R87.61 together with the conditions in its Excludes1 note: abnormal cytological findings in specimens from other female genital organs (R87.69), abnormal cytological findings in specimens from vagina (R87.62-), carcinoma in situ of cervix uteri (histologically confirmed) (D06.-), cervical intraepithelial neoplasia I [CIN I] (N87.0) and 4 more.

The conditions in its Excludes2 note aren't part of R87.61, but may be coded alongside it if the patient has both: cervical high risk human papillomavirus (HPV) DNA test positive (R87.810) and cervical low risk human papillomavirus (HPV) DNA test positive (R87.820).

It has been part of ICD-10-CM since the code set took effect on October 1, 2015 and hasn't changed since.

Specific codes under R87.61

Coding notes

Excludes1Not coded here — never report together with this code
  • abnormal cytological findings in specimens from other female genital organs (R87.69)
  • abnormal cytological findings in specimens from vagina (R87.62-)
  • carcinoma in situ of cervix uteri (histologically confirmed) (D06.-)
  • cervical intraepithelial neoplasia I [CIN I] (N87.0)
  • cervical intraepithelial neoplasia II [CIN II] (N87.1)
  • cervical intraepithelial neoplasia III [CIN III] (D06.-)
  • dysplasia (mild) (moderate) of cervix uteri (histologically confirmed) (N87.-)
  • severe dysplasia of cervix uteri (histologically confirmed) (D06.-)
Excludes2Not included here — may be reported together if both conditions exist
  • cervical high risk human papillomavirus (HPV) DNA test positive (R87.810)
  • cervical low risk human papillomavirus (HPV) DNA test positive (R87.820)

Notes that apply from higher levels

Instructions written at a parent level also apply to R87.61.

› From R87 Abnormal findings in specimens from female genital organs
Includes
  • abnormal findings in secretion and smears from cervix uteri
  • abnormal findings in secretion and smears from vagina
  • abnormal findings in secretion and smears from vulva

Broader instructions also apply from R83-R89 Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis and Chapter 18: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified.

Codes whose notes reference R87.61

Code history

  1. 2016
  2. 2017
  3. 2018
  4. 2019
  5. 2020
  6. 2021
  7. 2022
  8. 2023
  9. 2024
  10. 2025
  11. 2026
  12. 2027
  • FY2016 (effective 10/1/2015): Added (first year of ICD-10-CM)
  • No changes since FY2016.

Common questions about R87.61

Is R87.61 billable?

No. R87.61 is a header code. Report one of its more specific subcodes instead.